NGS (next generation sequencing) studies identified somatic mutations that generate a landscape of melanoma somatic mutations, including BRAF, NRAS, NF1, PTEN, CDKN2A and TP53, as driving mutations or potential tumor suppressors and oncogenes [9]. This evidence concerns the gene TP53 and melanoma.